CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H)
Authors
Dominique Berton-Rigaud
Jill Bowman
+8Â more
Mark Cornfeld
Christine Gennigens
Laurence Gladieff
Anna Kryzhanivska
Domenica Lorusso
Patricia Pautier
Chuan Tian
Toon Van Gorp
Publication date
1 January 2023
Publisher
Abstract
peer reviewe
Similar works
Full text
Available Versions
Open Repository and Bibliography - Liège
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:orbi.ulg.ac.be:2268/308445
Last time updated on 07/11/2023